ArticleNeurobiology of disease2026
Contribution of astrocytic calcium signaling to auditory hypersensitivity in a mouse model of fragile X syndrome.
Article in Neurobiology of disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Hippocampal Astrocytes Impact Postnatal Development of Inhibitory Connections, Parvalbumin Levels, Social, and Spatial Navigation Behaviors in a Mouse Model of Fragile X Syndrome.Journal of neurochemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Hypersensitivity to sensory stimuli is a common co-morbidity of Fragile X syndrome (FXS), the leading monogenic form of intellectual disability and autism spectrum disorder (ASD). Neuronal impairments associated with auditory and tactile hypersensitivity have been reported in the Fmr1 knockout mouse model of FXS. However, the contribution of astrocytes, in which Fmr1 is also expressed, to sensory hypersensitivity has not been defined. Using mice with astrocyte-specific deletion of Fmr1 (cKO) and mice with astrocyte-specific expression of Fmr1 (cON), we demonstrated that loss of astrocytic FMRP is sufficient but not necessary to confer susceptibility to audiogenic seizures (AGS), an indication of auditory hypersensitivity. Moreover, in vivo multiphoton imaging revealed increased astrocytic calcium signaling in Fmr1 KO mice. To test if enhanced astrocyte calcium signaling contributes to increased AGS, we crossed Fmr1 deletion mice to IP3R2 mutant mice. Reduced expression of IP3R2 rescued the AGS phenotype in the Fmr1 astrocyte cKO but not in the global Fmr1 KO mouse. Our results reveal that astrocytes contribute to AGS in mouse models of FXS through enhanced calcium signaling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.